Key PointsHealth insurer Humana shocked analysts with its full-year 2024 EPS cut to $16 versus $29.16 analyst estimates and full-year 2025 EPS cut to $6.00 to $10.00 versus $37.00 previous guidance.Humana stated that unprecedented cost surges in Medicare Advantage plan members driven by inpatient utilization spikes in November and December 2023 were the main cause.Humana is the country's second-largest Medicare Advantage plan provider behind UnitedHealth Group, which didn't cut its 2024 guidance.5 stocks we ...